AstraZeneca, BMS and BI among UK Prix Galien finalists.
FDA advisers voted 12-11 that Jardiance also reduces cardiovascular risks.
Sanofi and BI finalise CHC and animal health swap
Victoza results are significant, but fell short of investors’ expectations.
Pharma using FDA-mandated trials to give a commercial advantage.